Taysha Gene Therapies, Inc. (TSHA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.53B |
| Enterprise Value | 1.23B |
| P/E Ratio | -17.06 |
| PEG Ratio | 2.54 |
| Price/Sales Ratio | 190.46 |
| Price/Book Ratio | 11.3 |
| Enterprise/Revenue | 155.82 |
| Enterprise/EBITDA | -9.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -17.38 |
| Operating Margin | -17.74 |
| Return On Assets | -0.43 |
| Return On Equity | -0.56 |
| Revenue | 9.77M |
| Revenue/Share | 0.02 |
| Gross Profit | 9.77M |
| EBITDA | -107.79M |
| Net Income | -109M |
| Diluted EPS | -0.34 |
| Total Cash | 276.58M |
| Total Cash/Share | 0.75 |
| Total Debt | 17.77M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 14.04 |
| Book Value Per Share | 0.58 |
| 52-Week Change | 162.25 |
| 52-Week High | 7.3 |
| 52-Week Low | 2.25 |
| Moving Average 50 Days | 6 |
| Moving Average 200 Days | 4.9 |
| Average Volume | 2.72M |
| Shares Outstanding | 287.34M |
| % Held by Institutions | 83.08 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |